Answer any two and only two of the following.
a. Provide an overview of purine nucleotide biosynthesis and discuss its regulation.
b. Describe the urea cycle including its function, energy costs and regulation.
c. Give an overview of lysine, threonine, methionine, and isoleucine biosynthesis in bacteria and discuss its regulation.
d. Discuss the transcriptional control of the HMG-CoA reductase gene and over 20 other genes linked to cholesterol and fatty acid metabolism.
e. Compare and contrast the regulation of pyrimidine biosynthesis in bacteria and mammals.
a. Purines are heterocyclic bases.They are one of three components of nucleotides phosphate esters of a pentose sugar (either ribose or deoxyribose) in which a purine or pyrimidine base is linked to C1 of the sugar and closed ring structures comprised of at least two different kinds of atoms.
Purine biosynthesis occurs in the cytosol of all cells. The purine ring is built up in a series of 11 enzyme catalysed steps. Each enzyme is oligomeric, which means it contains several monomers. Intermediate products that are produced during the reaction are not released. Instead, they are shuttled to the subsequent enzyme along the pathway.
Step one of this pathway generates an important compound, 5-phosphoribosyl-alpha-pyrophosphate (PRPP). This compound is also a precursor in the biosynthesis of pyrimidine nucleotides. It provides the phospho-ribose units of these ribonucleotides.
PRPP is derived from ribose-5-phosphate (R5P) a product of the pentose phosphate pathway. Therefore, purines are built from a series of addition reactions to a sugar.
Purine synthesis yields inosine monophosphate
In the first step of purine biosynthesis, ribose phosphate pyrophosphokinase activates the ribose by reacting it with ATP to form 5-phosphoribosyl-alpha-pyrophosphate (PRPP).
Step 2 is the committed step of purine biosynthesis. In this reaction amidophosphoribosyl transferase catalyses the displacement of PRPP’s pyrophosphate group by glutamine’s amide nitrogen. This reaction is the pathway’s flux-controlling step (the rate at which the biosynthetic pathway outputs product) . Following the remaining 9 steps, the first purine derivative that is synthesised is inosine monophosphate (IMP).IMP is the precursor for the purine nucleotide, adenosine and guanosine monophosphate (AMP and GMP). Each are synthesized in a two-reaction pathway with bifurcates at the level of IMP:
Further phosphate additions to generate diphosphate and triphosphate nucleosides may follow completion of monophosphate synthesis. These reactions are carried out by kinases.
Kinases are so-called due to their property of transferring phosphate groups from a high-energy phosphate molecule to specific substrates. The complete nucleotide triphosphate forms, adenosine and guanosine triphosphate (ATP and GTP) are the recognizable units of RNA and DNA. Therefore, purines are initially formed as ribonucleotides rather than as free bases.
Purine nucleotide biosynthesis is regulated at several steps
This is crucial to prevent the waste of
(1) energy and nitrogen
(2) to control the total amounts of purine nucleotides available for nucleic acid synthesis
(3) the purine waste product, uric acid are harmful to cells.Excessive uric acid production leads to its deposition in joints causing pain and redness.
IMP synthesis is controlled by the levels of adenine and guanine nucleotides. Additional control is exerted by feedforward activation which is the stimulation of a subsequent enzyme by the preceding substrate. In this situation, the amidophosphoribosyl transferase I step 2 is allosterically stimulated by PRPP, the product of step 1.
The second level of regulation occurs at the branch point below IMP, leading to either AMP or GMP. These end products are each competitive inhibitors of IMP and so, their excessive build-up is prevented.
The metabolic requirement for purine can be fulfilled by biosynthesis in the human body. Without adequate production of purines, or because of abnormal biosynthetic pathways, painful clinical manifestations can arise.
b. Urea cycle
The urea cycle is the metabolic pathway that transforms nitrogen to urea for excretion from the body.
Urea is formed in the urea cycle from NH4+, CO2, and the nitrogen of aspartate.The cycle occurs mainly in the liver.
Cytosol and mitochondria of hepatocytes.The Substrates used are NH3 (as derived from oxidative deamination of glutamate) CO2 ,aspartate ,three ATP.The products formed are Urea, fumarate,H2O.
Steps in Urea cycle
1.Transport of nitrogen to the liver
Ammonia is very toxic, particularly to the central nervous system.The concentration of ammonia and ammonium ions in the blood is normally very low.
(NH3 + H+ ↔ NH4+)
Ammonia travels to the liver from other tissues, mainly in the form of alanine and glutamine.It is released from amino acids in the liver by a series of transamination and deamination reactions.Ammonia is also produced by bacteria in the gut and travels to the liver via the hepatic portal vein.
2. Reactions of the urea cycle
NH4+ and aspartate provide the nitrogen that is used to produce urea and CO2 provides the carbon. Ornithine serves as a carrier that is regenerated by the cycle.Carbamoyl phosphate is synthesized in the first reaction from NH4+, CO2 and two ATP. Inorganic phosphate and two ADP are also produced.
Arginine is a nonessential amino acid in adults. It is synthesized from glucose via ornithine and the first four reactions of the urea cycle.
Regulation of Urea cycle
Purpose of the Urea cycle is it allows for the excretion of NH4+ by transforming ammonia into urea, which is then excreted by the kidneys.
Enzymes involved in Urea cycle are
a. Provide an overview of purine nucleotide biosynthesis and discuss its regulation.
1- Which of the following statements about cholesterol regulation is false? A) Insulin stimulates the production of cholesterol. B) High intracellular cholesterol levels stimulate proteolysis of HMG-CoA reductase. C) High intracellular cholesterol levels inhibit the uptake of extracellular cholesterol. D) Glucagon stimulates the production of cholesterol. 2- Which statement is incorrect about the synthesis of fatty acids by fatty acid synthase in mammals? A) It uses FADH2 as a reductant of carbon-carbon double bonds. B) It uses NADPH as a...
Can someone please check my answers and aid in #12? 1. The amide nitrogen of glutamine: A. represents a nontoxic transport form of ammonia. B. is a major source of ammonia for urinary excretion. C. is used in the synthesis of asparagine, purines, and pynimidines. D. can be recovered as ammonia by the action of glutaminase. E. all of the above are correct. 2- Which of the following statements about glutamate is NOT true: a It can be synthesized in...